← FDA Drug Approvals (Drugs@FDA)

TERIPARATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2025-12-12

Drug application

FDA Application #

ANDA213641

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERIPARATIDE

Generic name

TERIPARATIDE

Active ingredients

TERIPARATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AMPHASTAR PHARMS INC

Manufacturer

Amphastar Pharmaceuticals, Inc.

First approval

2025-12-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown